Ipsen
Molly Reed is an experienced professional in the pharmaceutical industry, currently serving as the Associate Director in Preclinical Data and Integration on the REED Strategy and Operations Team at Ipsen since April 2022. Previous experience includes the role of Science Submission Manager at AstraZeneca from September 2018 to May 2022, and a tenure at MedImmune spanning nearly a decade, where Molly Reed held positions as an Associate Toxicologist and Research Technician. Molly Reed holds a Bachelor's degree in Animal Sciences from Virginia Tech, completed in 2008, and further education at the University of Maryland Global Campus.
This person is not in any teams
This person is not in any offices
Ipsen
22 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.